In conclusion, we demonstrate the potential of TGFβ1 and CTGF to mitigate the progression of disc degeneration and the potential use of these molecules in a molecular therapy to treat the degenerative disc. This evidence concerns the gene TGFB1 and intervertebral disk degenerative disorder.